Quality of methods reporting in animal models of colitis

Inflammatory Bowel Diseases

Volumn 21, Issue 6, 2015, Pages 1248-1259

  Bramhall, Michael ^a   Florez Vargas, Oscar ^a   Stevens, Robert ^a   Brass, Andy ^a   Cruickshank, Sheena ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

animal models; checklist; colitis; IBD; methods

Indexed keywords

CD45RB ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 10; TRINITROBENZENESULFONIC ACID; CD45 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL HOUSING; ANIMAL MODEL; ARTICLE; CELL TRANSFER; CHECKLIST; CHEMICALLY INDUCED DISORDER; CLINICAL RESEARCH; COLITIS; DNA MODIFICATION; EXPERIMENTAL DESIGN; GENE EXPRESSION; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; SYSTEMATIC REVIEW; T LYMPHOCYTE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; HUMAN; INFLAMMATORY BOWEL DISEASE; METHODOLOGY; STANDARDS;

ANIMALS; ANTIGENS, CD45; CHECKLIST; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; RESEARCH DESIGN; TRINITROBENZENESULFONIC ACID;

EID: 84929916750     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000369     Document Type: Article

References (101)

1. Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol. 2014;11:372-385.
2. Mizoguchi A. Animal models of inflammatory bowel disease. In: Conn PM, ed. Progress in Molecular Biology and Translational Science. London, United kingdom: Academic Press; 2012;105:263-320.
3. Goyal N, Rana A, Ahlawat A, et al. Animal models of inflammatory bowel disease: a review. Inflammopharmacology. 2014;22:219-233.
4. Kamada N, Seo SU, Chen GY, et al. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13:321-335.
5. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383: 267-276.
6. Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.
7. Noorden RV. Parasite test shows where validation studies can go wrong [Nature News web site]. 2014. Available at: http://www.nature.com/news/parasite-test-shows-where-validation-studies-can-go-wrong-1.16527WT.mcidTWTNatureNews. Accessed December 19, 2014.
8. Taylor CF, Field D, Sansone SA, et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol. 2008;26:889-896.
9. Landis SC, Amara SG, Asadullah K, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012; 490:187-191.
10. Raising standards. Nat Genet. 2013;45:467.
11. Baker D, Lidster K, Sottomayor A, et al. Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for preclinical animal studies. PLoS Biol. 2014;12:e1001756.
12. Flórez-Vargas O, Bramhall M, Noyes H, et al. The quality of methods reporting in parasitology experiments. PLoS One. 2014;9:e101131.
13. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36-49.
14. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013;6:295-308.
15. Hekmatdoost A, Feizabadi MM, Djazayery A, et al. The effect of dietary oils on cecal microflora in experimental colitis in mice. Indian J Gastroenterol. 2008;27:186-189.
16. Hufeldt MR, Nielsen DS, Vogensen FK, et al. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comp Med. 2010;60:336-347.
17. Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35:347-369.
18. Olfe J, Domanska G, Schuett C, et al. Different stress-related phenotypes of BALB/c mice from in-house or vendor: alterations of the sympathetic and HPA axis responsiveness. BMC Physiol. 2010;10:2.
19. Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:13.
20. Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther. 2013;7: 1341-1357.
21. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32: 23-63.
22. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
23. Ostanin DV, Bao J, Koboziev I, et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009;296:135-146.
24. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541-546.
25. A little knowledge. Nature. 2014;514:139-140.
26. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
27. Levison SE, McLaughlin JT, Zeef LA, et al. Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: phenotyping a chronic colitis and lessons for iatrogenic helminthosis. Inflamm Bowel Dis. 2010;16:2065-2079.
28. Benight NM, Stoll B, Marini JC, et al. Preventative oral methylthioadenosine is anti-inflammatory and reduces DSS-induced colitis in mice. Am J Physiol Gastrointest Liver Physiol. 2012;303:G71-G82.
29. Breynaert C, Dresselaers T, Perrier C, et al. Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease. PLoS One. 2013;8:e68876.
30. Cho JY, Chi SG, Chun HS. Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice. Mol Nutr Food Res. 2011;55:239-246.
31. Cho JY, Hwang JK, Chun HS. Xanthorrhizol attenuates dextran sulfate sodium-induced colitis via the modulation of the expression of inflammatory genes in mice. Life Sci. 2011;88:864-870.
32. Chung SH, Park YS, Kim OS, et al. Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis. Dig Dis Sci. 2014;59:1134-1141.
33. Coburn LA, Gong X, Singh K, et al. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One. 2012;7:e33546.
34. Fang K, Bruce M, Pattillo CB, et al. Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol Genomics. 2011;43:43-56.
35. Hamilton MJ, Sinnamon MJ, Lyng GD, et al. Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci USA. 2011; 108:290-295.
36. Hansen JJ, Holt L, Sartor RB. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis. 2009;15:890-899.
37. Hontecillas R, Horne WT, Climent M, et al. Immunoregulatory mechanisms of macrophage PPAR-gamma in mice with experimental inflammatory bowel disease. Mucosal Immunol. 2011;4:304-313.
38. Iizuka Y, Okuno T, Saeki K, et al. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J. 2010;24:4678-4690.
39. Jia Q, Ivanov I, Zlatev ZZ, et al. Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. Br J Nutr. 2011;106:519-529.
40. Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002;109:883-893.
41. Kellermayer R, Balasa A, Zhang W, et al. Epigenetic maturation in colonic mucosa continues beyond infancy in mice. Hum Mol Genet. 2010;19:2168-2176.
42. Kiela PR, Laubitz D, Larmonier CB, et al. Changes in mucosal homeostasis predispose NHE3 knockout mice to increased susceptibility to DSS-induced epithelial injury. Gastroenterology. 2009;137:965-975, 975e1-975e10.
43. Lagishetty V, Misharin AV, Liu NQ, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423-2432.
44. Lara-Villoslada F, Debras E, Nieto A, et al. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr. 2006;25:477-488.
45. Larrosa M, Yanez-Gascon MJ, Selma MV, et al. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J Agric Food Chem. 2009;57:2211-2220.
46. Lee H, Ahn YT, Lee JH, et al. Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis. Inflammation. 2009; 32:379-386.
47. Lopez-Dee ZP, Chittur SV, Patel B, et al. Thrombospondin-1 type 1 repeats in a model of inflammatory bowel disease: transcript profile and therapeutic effects. PLoS One. 2012;7:e34590.
48. Mannick EE, Cote RL, Schurr JR, et al. Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice. J Gastroenterol Hepatol. 2005;20:371-380.
49. Mizoguchi E. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology. 2006;130:398-411.
50. Mizoguchi E, Xavier RJ, Reinecker HC, et al. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology. 2003;125:148-161.
51. Nakajima A, Wada K, Katayama K, et al. Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice. J Gastroenterol. 2002;37(suppl 14):62-66.
52. Reikvam DH, Derrien M, Islam R, et al. Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice. Eur J Immunol. 2012;42: 2959-2970.
53. Sainathan SK, Bishnupuri KS, Aden K, et al. Toll-like receptor-7 ligand imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis. Inflamm Bowel Dis. 2012;18:955-967.
54. Sainathan SK, Hanna EM, Gong Q, et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis. 2008;14:88-99.
55. Schaible TD, Harris RA, Dowd SE, et al. Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet. 2011;20:1687-1696.
56. Te Velde AA, De Kort F, Sterrenburg E, et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:325-330.
57. Barnett MP, McNabb WC, Cookson AL, et al. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol. 2010;11:39.
58. de Buhr MF, Mahler M, Geffers R, et al. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics. 2006;25:426-434.
59. Edmunds SJ, Roy NC, Davy M, et al. Effects of kiwifruit extracts on colonic gene and protein expression levels in IL-10 gene-deficient mice. Br J Nutr. 2012;108:113-129.
60. Hemmerling J, Heller K, Hormannsperger G, et al. Fetal exposure to maternal inflammation does not affect postnatal development of genetically-driven ileitis and colitis. PLoS One. 2014;9:e98237.
61. Huang Z, Shi T, Zhou Q, et al. miR-141 regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn's disease. Gut. 2014;63:1247-1257.
62. Knoch B, Barnett MP, Cooney J, et al. Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. Biotechnol J. 2010;5:1226-1240.
63. Knoch B, Barnett MP, McNabb WC, et al. Dietary arachidonic acidmediated effects on colon inflammation using transcriptome analysis. Mol Nutr Food Res. 2010;54(suppl 1):S62-S74.
64. Knoch B, Barnett MP, Zhu S, et al. Genome-wide analysis of dietary eicosapentaenoic acid-and oleic acid-induced modulation of colon inflammation in interleukin-10 gene-deficient mice. J Nutrigenet Nutrigenomics. 2009;2:9-28.
65. Kuo SM, Chan WC, Hu Z. Wild-type and IL10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifidobacterium animalis subspecies lactis and inulin. J Nutr. 2014;144:245-251.
66. Reiff C, Delday M, Rucklidge G, et al. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15:1721-1736.
67. Roy N, Barnett M, Knoch B, et al. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid-and arachidonic acid-enriched diets. Mutat Res. 2007;622:103-116.
68. Russ AE, Peters JS, McNabb WC, et al. Gene expression changes in the colon epithelium are similar to those of intact colon during late inflammation in interleukin-10 gene deficient mice. PLoS One. 2013;8:e63251.
69. Brudzewsky D, Pedersen AE, Claesson MH, et al. Genome-wide gene expression profiling of SCID mice with T-cell-mediated Colitis. Scand J Immunol. 2009;69:437-446.
70. Fang K, Zhang S, Glawe J, et al. Temporal genome expression profile analysis during T-cell-mediated colitis: identification of novel targets and pathways. Inflamm Bowel Dis. 2012;18:1411-1423.
71. Kristensen NN, Olsen J, Gad M, et al. Genome-wide expression profiling during protection from colitis by regulatory T cells. Inflamm Bowel Dis. 2008;14:75-87.
72. Rivollier A, He J, Kole A, et al. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med. 2012;209:139-155.
73. Abad C, Juarranz Y, Martinez C, et al. cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP. Inflamm Bowel Dis. 2005;11:674-684.
74. Billerey-Larmonier C, Uno JK, Larmonier N, et al. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis. 2008;14:780-793.
75. Brenna O, Furnes MW, Drozdov I, et al. Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and transcriptomic [corrected] characterization and correlation to IBD. PLoS One. 2013;8:e54543.
76. Guzman J, Yu JG, Suntres Z, et al. ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Inflamm Bowel Dis. 2006;12:766-789.
77. Kremer B, Mariman R, van Erk M, et al. Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes. PLoS One. 2012;7:e50388.
78. Mariman R, Kremer B, van Erk M, et al. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis. 2012;18:1424-1433.
79. Martinez-Augustin O, Merlos M, Zarzuelo A, et al. Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC Genomics. 2008;9:490.
80. Nur T, Peijnenburg AA, Noteborn HP, et al. DNA microarray technology reveals similar gene expression patterns in rats with vitamin a deficiency and chemically induced colitis. J Nutr. 2002;132:2131-2136.
81. Rivera E, Flores I, Appleyard CB. Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets. Inflamm Bowel Dis. 2006;12:950-966.
82. Wu F, Chakravarti S. Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis. J Immunol. 2007;179:6988-7000.
83. Yamamoto S, Isuzugawa K, Takahashi Y, et al. Intestinal gene expression in TNBS treated mice using genechip and subtractive cDNA analysis: implications for Crohn's disease. Biol Pharm Bull. 2005; 28:2046-2053.
84. Zhou W, Cao Q, Peng Y, et al. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology. 2009; 137:1403-1414.
85. Zwiers A, Fuss IJ, Leijen S, et al. Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis. Inflamm Bowel Dis. 2008;14:1652-1659.
86. NC3Rs. The 3Rs [NC3Rs web site]. Available at: http://www.nc3rs.org. uk/the-3rs. Accessed 23 October, 2014.
87. Home Office. Guidance on the Operation of the Animals (Scientific Procedures) Act 1986. London, United Kingdom: HMSO; 2014.
88. Clarke M. Standardising outcomes for clinical trials and systematic reviews. Trials. 2007;8:39.
89. Couzin-Frankel J. When mice mislead. Science. 2013;342:922-925.
90. Check Hayden E. Misleading mouse studies waste medical resources. Nature News. 26 March, 2014.
91. Rogers GB, Kozlowska J, Keeble J, et al. Functional divergence in gastrointestinal microbiota in physically-separated genetically identical mice. Sci Rep. 2014;4:5437.
92. Obernier JA, Baldwin RL. Establishing an appropriate period of acclimatization following transportation of laboratory animals. ILAR J. 2006; 47:364-369.
93. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-249.
94. Laying better plans for mice. Nat Biotechnol. 2013;31:263.
95. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8:737-744.
96. Karp CL. Unstressing intemperate models: how cold stress undermines mouse modeling. J Exp Med. 2012;209:1069-1074.
97. Kokolus KM, Capitano ML, Lee CT, et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci USA. 2013;110: 20176-20181.
98. Rabin BS, Lyte M, Epstein LH, et al. Alteration of immune competency by number of mice housed per cage. Ann N Y Acad Sci. 1987; 496:492-500.
99. Kitajima S, Takuma S, Morimoto M. Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp Anim. 2000;49:9-15.
100. Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4:303-306.
101. Kozlowski C, Jeet S, Beyer J, et al. An entirely automated method to score DSS-induced colitis in mice by digital image analysis of pathology slides. Dis Model Mech. 2013;6:855-865.